Global Eosinophilic Granulomatosis Market Research Report 2025(Status and Outlook)

September 2025 | 144 pages | ID: G794EA5A8C0BEN
Bosson Research

Abstracts

Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is a rare systemic autoimmune disorder characterized by inflammation of small to medium-sized blood vessels, leading to eosinophil-rich granulomatous inflammation and necrotizing vasculitis, primarily affecting the respiratory tract, peripheral nerves, skin, heart, and gastrointestinal system. It is classified as a type of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, although not all patients are ANCA-positive, and its clinical presentation often includes severe asthma, chronic rhinosinusitis, and marked peripheral blood eosinophilia. Diagnosis relies on a combination of clinical criteria, histopathological findings, laboratory tests (including elevated eosinophil counts and ANCA serology), and imaging studies, while treatment typically involves corticosteroids and immunosuppressive agents to induce and maintain remission, with newer biologic therapies like mepolizumab (an anti-IL-5 monoclonal antibody) showing efficacy in reducing relapses and steroid dependence in certain patient subgroups.

The global Eosinophilic Granulomatosis market size was estimated at USD 650.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Eosinophilic Granulomatosis market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Eosinophilic Granulomatosis market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Eosinophilic Granulomatosis market.

Global Eosinophilic Granulomatosis Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

GlaxoSmithKline
Pharmaceuticals Holdings
Baxter
Genentech(Roche)
Cephalon(Teva)
Amgen
Sanofi
DSM
AstraZeneca
Novartis International

Market Segmentation (by Type)

Oral
Intravenous
Others

Market Segmentation (by Application)

Hospital Pharmacies
Drug Stores
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Eosinophilic Granulomatosis Market
Overview of the regional outlook of the Eosinophilic Granulomatosis Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Eosinophilic Granulomatosis Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Eosinophilic Granulomatosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Eosinophilic Granulomatosis
1.2 Key Market Segments
  1.2.1 Eosinophilic Granulomatosis Segment by Type
  1.2.2 Eosinophilic Granulomatosis Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 EOSINOPHILIC GRANULOMATOSIS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Eosinophilic Granulomatosis Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Eosinophilic Granulomatosis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 EOSINOPHILIC GRANULOMATOSIS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Eosinophilic Granulomatosis Product Life Cycle
3.3 Global Eosinophilic Granulomatosis Sales by Manufacturers (2020-2025)
3.4 Global Eosinophilic Granulomatosis Revenue Market Share by Manufacturers (2020-2025)
3.5 Eosinophilic Granulomatosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Eosinophilic Granulomatosis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Eosinophilic Granulomatosis Market Competitive Situation and Trends
  3.8.1 Eosinophilic Granulomatosis Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Eosinophilic Granulomatosis Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 EOSINOPHILIC GRANULOMATOSIS INDUSTRY CHAIN ANALYSIS

4.1 Eosinophilic Granulomatosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF EOSINOPHILIC GRANULOMATOSIS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Eosinophilic Granulomatosis Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Eosinophilic Granulomatosis Market
5.7 ESG Ratings of Leading Companies

6 EOSINOPHILIC GRANULOMATOSIS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Eosinophilic Granulomatosis Sales Market Share by Type (2020-2025)
6.3 Global Eosinophilic Granulomatosis Market Size Market Share by Type (2020-2025)
6.4 Global Eosinophilic Granulomatosis Price by Type (2020-2025)

7 EOSINOPHILIC GRANULOMATOSIS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Eosinophilic Granulomatosis Market Sales by Application (2020-2025)
7.3 Global Eosinophilic Granulomatosis Market Size (M USD) by Application (2020-2025)
7.4 Global Eosinophilic Granulomatosis Sales Growth Rate by Application (2020-2025)

8 EOSINOPHILIC GRANULOMATOSIS MARKET SALES BY REGION

8.1 Global Eosinophilic Granulomatosis Sales by Region
  8.1.1 Global Eosinophilic Granulomatosis Sales by Region
  8.1.2 Global Eosinophilic Granulomatosis Sales Market Share by Region
8.2 Global Eosinophilic Granulomatosis Market Size by Region
  8.2.1 Global Eosinophilic Granulomatosis Market Size by Region
  8.2.2 Global Eosinophilic Granulomatosis Market Size Market Share by Region
8.3 North America
  8.3.1 North America Eosinophilic Granulomatosis Sales by Country
  8.3.2 North America Eosinophilic Granulomatosis Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Eosinophilic Granulomatosis Sales by Country
  8.4.2 Europe Eosinophilic Granulomatosis Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Eosinophilic Granulomatosis Sales by Region
  8.5.2 Asia Pacific Eosinophilic Granulomatosis Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Eosinophilic Granulomatosis Sales by Country
  8.6.2 South America Eosinophilic Granulomatosis Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Eosinophilic Granulomatosis Sales by Region
  8.7.2 Middle East and Africa Eosinophilic Granulomatosis Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 EOSINOPHILIC GRANULOMATOSIS MARKET PRODUCTION BY REGION

9.1 Global Production of Eosinophilic Granulomatosis by Region(2020-2025)
9.2 Global Eosinophilic Granulomatosis Revenue Market Share by Region (2020-2025)
9.3 Global Eosinophilic Granulomatosis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Eosinophilic Granulomatosis Production
  9.4.1 North America Eosinophilic Granulomatosis Production Growth Rate (2020-2025)
  9.4.2 North America Eosinophilic Granulomatosis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Eosinophilic Granulomatosis Production
  9.5.1 Europe Eosinophilic Granulomatosis Production Growth Rate (2020-2025)
  9.5.2 Europe Eosinophilic Granulomatosis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Eosinophilic Granulomatosis Production (2020-2025)
  9.6.1 Japan Eosinophilic Granulomatosis Production Growth Rate (2020-2025)
  9.6.2 Japan Eosinophilic Granulomatosis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Eosinophilic Granulomatosis Production (2020-2025)
  9.7.1 China Eosinophilic Granulomatosis Production Growth Rate (2020-2025)
  9.7.2 China Eosinophilic Granulomatosis Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GlaxoSmithKline
  10.1.1 GlaxoSmithKline Basic Information
  10.1.2 GlaxoSmithKline Eosinophilic Granulomatosis Product Overview
  10.1.3 GlaxoSmithKline Eosinophilic Granulomatosis Product Market Performance
  10.1.4 GlaxoSmithKline Business Overview
  10.1.5 GlaxoSmithKline SWOT Analysis
  10.1.6 GlaxoSmithKline Recent Developments
10.2 Pharmaceuticals Holdings
  10.2.1 Pharmaceuticals Holdings Basic Information
  10.2.2 Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Overview
  10.2.3 Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Market Performance
  10.2.4 Pharmaceuticals Holdings Business Overview
  10.2.5 Pharmaceuticals Holdings SWOT Analysis
  10.2.6 Pharmaceuticals Holdings Recent Developments
10.3 Baxter
  10.3.1 Baxter Basic Information
  10.3.2 Baxter Eosinophilic Granulomatosis Product Overview
  10.3.3 Baxter Eosinophilic Granulomatosis Product Market Performance
  10.3.4 Baxter Business Overview
  10.3.5 Baxter SWOT Analysis
  10.3.6 Baxter Recent Developments
10.4 Genentech(Roche)
  10.4.1 Genentech(Roche) Basic Information
  10.4.2 Genentech(Roche) Eosinophilic Granulomatosis Product Overview
  10.4.3 Genentech(Roche) Eosinophilic Granulomatosis Product Market Performance
  10.4.4 Genentech(Roche) Business Overview
  10.4.5 Genentech(Roche) Recent Developments
10.5 Cephalon(Teva)
  10.5.1 Cephalon(Teva) Basic Information
  10.5.2 Cephalon(Teva) Eosinophilic Granulomatosis Product Overview
  10.5.3 Cephalon(Teva) Eosinophilic Granulomatosis Product Market Performance
  10.5.4 Cephalon(Teva) Business Overview
  10.5.5 Cephalon(Teva) Recent Developments
10.6 Amgen
  10.6.1 Amgen Basic Information
  10.6.2 Amgen Eosinophilic Granulomatosis Product Overview
  10.6.3 Amgen Eosinophilic Granulomatosis Product Market Performance
  10.6.4 Amgen Business Overview
  10.6.5 Amgen Recent Developments
10.7 Sanofi
  10.7.1 Sanofi Basic Information
  10.7.2 Sanofi Eosinophilic Granulomatosis Product Overview
  10.7.3 Sanofi Eosinophilic Granulomatosis Product Market Performance
  10.7.4 Sanofi Business Overview
  10.7.5 Sanofi Recent Developments
10.8 DSM
  10.8.1 DSM Basic Information
  10.8.2 DSM Eosinophilic Granulomatosis Product Overview
  10.8.3 DSM Eosinophilic Granulomatosis Product Market Performance
  10.8.4 DSM Business Overview
  10.8.5 DSM Recent Developments
10.9 AstraZeneca
  10.9.1 AstraZeneca Basic Information
  10.9.2 AstraZeneca Eosinophilic Granulomatosis Product Overview
  10.9.3 AstraZeneca Eosinophilic Granulomatosis Product Market Performance
  10.9.4 AstraZeneca Business Overview
  10.9.5 AstraZeneca Recent Developments
10.10 Novartis International
  10.10.1 Novartis International Basic Information
  10.10.2 Novartis International Eosinophilic Granulomatosis Product Overview
  10.10.3 Novartis International Eosinophilic Granulomatosis Product Market Performance
  10.10.4 Novartis International Business Overview
  10.10.5 Novartis International Recent Developments

11 EOSINOPHILIC GRANULOMATOSIS MARKET FORECAST BY REGION

11.1 Global Eosinophilic Granulomatosis Market Size Forecast
11.2 Global Eosinophilic Granulomatosis Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Eosinophilic Granulomatosis Market Size Forecast by Country
  11.2.3 Asia Pacific Eosinophilic Granulomatosis Market Size Forecast by Region
  11.2.4 South America Eosinophilic Granulomatosis Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Eosinophilic Granulomatosis by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Eosinophilic Granulomatosis Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Eosinophilic Granulomatosis by Type (2026-2033)
  12.1.2 Global Eosinophilic Granulomatosis Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Eosinophilic Granulomatosis by Type (2026-2033)
12.2 Global Eosinophilic Granulomatosis Market Forecast by Application (2026-2033)
  12.2.1 Global Eosinophilic Granulomatosis Sales (K MT) Forecast by Application
  12.2.2 Global Eosinophilic Granulomatosis Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Eosinophilic Granulomatosis Market Size Comparison by Region (M USD)
Table 5. Global Eosinophilic Granulomatosis Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Eosinophilic Granulomatosis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Eosinophilic Granulomatosis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Eosinophilic Granulomatosis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Granulomatosis as of 2024)
Table 10. Global Market Eosinophilic Granulomatosis Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Eosinophilic Granulomatosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Eosinophilic Granulomatosis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Eosinophilic Granulomatosis Sales by Type (K MT)
Table 26. Global Eosinophilic Granulomatosis Market Size by Type (M USD)
Table 27. Global Eosinophilic Granulomatosis Sales (K MT) by Type (2020-2025)
Table 28. Global Eosinophilic Granulomatosis Sales Market Share by Type (2020-2025)
Table 29. Global Eosinophilic Granulomatosis Market Size (M USD) by Type (2020-2025)
Table 30. Global Eosinophilic Granulomatosis Market Size Share by Type (2020-2025)
Table 31. Global Eosinophilic Granulomatosis Price (USD/KG) by Type (2020-2025)
Table 32. Global Eosinophilic Granulomatosis Sales (K MT) by Application
Table 33. Global Eosinophilic Granulomatosis Market Size by Application
Table 34. Global Eosinophilic Granulomatosis Sales by Application (2020-2025) & (K MT)
Table 35. Global Eosinophilic Granulomatosis Sales Market Share by Application (2020-2025)
Table 36. Global Eosinophilic Granulomatosis Market Size by Application (2020-2025) & (M USD)
Table 37. Global Eosinophilic Granulomatosis Market Share by Application (2020-2025)
Table 38. Global Eosinophilic Granulomatosis Sales Growth Rate by Application (2020-2025)
Table 39. Global Eosinophilic Granulomatosis Sales by Region (2020-2025) & (K MT)
Table 40. Global Eosinophilic Granulomatosis Sales Market Share by Region (2020-2025)
Table 41. Global Eosinophilic Granulomatosis Market Size by Region (2020-2025) & (M USD)
Table 42. Global Eosinophilic Granulomatosis Market Size Market Share by Region (2020-2025)
Table 43. North America Eosinophilic Granulomatosis Sales by Country (2020-2025) & (K MT)
Table 44. North America Eosinophilic Granulomatosis Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Eosinophilic Granulomatosis Sales by Country (2020-2025) & (K MT)
Table 46. Europe Eosinophilic Granulomatosis Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Eosinophilic Granulomatosis Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Eosinophilic Granulomatosis Market Size by Region (2020-2025) & (M USD)
Table 49. South America Eosinophilic Granulomatosis Sales by Country (2020-2025) & (K MT)
Table 50. South America Eosinophilic Granulomatosis Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Eosinophilic Granulomatosis Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Eosinophilic Granulomatosis Market Size by Region (2020-2025) & (M USD)
Table 53. Global Eosinophilic Granulomatosis Production (K MT) by Region(2020-2025)
Table 54. Global Eosinophilic Granulomatosis Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Eosinophilic Granulomatosis Revenue Market Share by Region (2020-2025)
Table 56. Global Eosinophilic Granulomatosis Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Eosinophilic Granulomatosis Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Eosinophilic Granulomatosis Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Eosinophilic Granulomatosis Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Eosinophilic Granulomatosis Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. GlaxoSmithKline Basic Information
Table 62. GlaxoSmithKline Eosinophilic Granulomatosis Product Overview
Table 63. GlaxoSmithKline Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. Pharmaceuticals Holdings Basic Information
Table 68. Pharmaceuticals Holdings Eosinophilic Granulomatosis Product Overview
Table 69. Pharmaceuticals Holdings Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Pharmaceuticals Holdings Business Overview
Table 71. Pharmaceuticals Holdings SWOT Analysis
Table 72. Pharmaceuticals Holdings Recent Developments
Table 73. Baxter Basic Information
Table 74. Baxter Eosinophilic Granulomatosis Product Overview
Table 75. Baxter Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Baxter Business Overview
Table 77. Baxter SWOT Analysis
Table 78. Baxter Recent Developments
Table 79. Genentech(Roche) Basic Information
Table 80. Genentech(Roche) Eosinophilic Granulomatosis Product Overview
Table 81. Genentech(Roche) Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Genentech(Roche) Business Overview
Table 83. Genentech(Roche) Recent Developments
Table 84. Cephalon(Teva) Basic Information
Table 85. Cephalon(Teva) Eosinophilic Granulomatosis Product Overview
Table 86. Cephalon(Teva) Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Cephalon(Teva) Business Overview
Table 88. Cephalon(Teva) Recent Developments
Table 89. Amgen Basic Information
Table 90. Amgen Eosinophilic Granulomatosis Product Overview
Table 91. Amgen Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. Sanofi Basic Information
Table 95. Sanofi Eosinophilic Granulomatosis Product Overview
Table 96. Sanofi Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Sanofi Business Overview
Table 98. Sanofi Recent Developments
Table 99. DSM Basic Information
Table 100. DSM Eosinophilic Granulomatosis Product Overview
Table 101. DSM Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. DSM Business Overview
Table 103. DSM Recent Developments
Table 104. AstraZeneca Basic Information
Table 105. AstraZeneca Eosinophilic Granulomatosis Product Overview
Table 106. AstraZeneca Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Recent Developments
Table 109. Novartis International Basic Information
Table 110. Novartis International Eosinophilic Granulomatosis Product Overview
Table 111. Novartis International Eosinophilic Granulomatosis Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Novartis International Business Overview
Table 113. Novartis International Recent Developments
Table 114. Global Eosinophilic Granulomatosis Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Eosinophilic Granulomatosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Eosinophilic Granulomatosis Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Eosinophilic Granulomatosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Eosinophilic Granulomatosis Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Eosinophilic Granulomatosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Eosinophilic Granulomatosis Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Eosinophilic Granulomatosis Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Eosinophilic Granulomatosis Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Eosinophilic Granulomatosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Eosinophilic Granulomatosis Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Eosinophilic Granulomatosis Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Eosinophilic Granulomatosis Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Eosinophilic Granulomatosis Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Eosinophilic Granulomatosis Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Eosinophilic Granulomatosis Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Eosinophilic Granulomatosis Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Eosinophilic Granulomatosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Eosinophilic Granulomatosis Market Size (M USD), 2024-2033
Figure 5. Global Eosinophilic Granulomatosis Market Size (M USD) (2020-2033)
Figure 6. Global Eosinophilic Granulomatosis Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Eosinophilic Granulomatosis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Eosinophilic Granulomatosis Product Life Cycle
Figure 13. Eosinophilic Granulomatosis Sales Share by Manufacturers in 2024
Figure 14. Global Eosinophilic Granulomatosis Revenue Share by Manufacturers in 2024
Figure 15. Eosinophilic Granulomatosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Eosinophilic Granulomatosis Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Eosinophilic Granulomatosis Revenue in 2024
Figure 18. Industry Chain Map of Eosinophilic Granulomatosis
Figure 19. Global Eosinophilic Granulomatosis Market PEST Analysis
Figure 20. Global Eosinophilic Granulomatosis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Eosinophilic Granulomatosis Market Share by Type
Figure 27. Sales Market Share of Eosinophilic Granulomatosis by Type (2020-2025)
Figure 28. Sales Market Share of Eosinophilic Granulomatosis by Type in 2024
Figure 29. Market Size Share of Eosinophilic Granulomatosis by Type (2020-2025)
Figure 30. Market Size Share of Eosinophilic Granulomatosis by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Eosinophilic Granulomatosis Market Share by Application
Figure 33. Global Eosinophilic Granulomatosis Sales Market Share by Application (2020-2025)
Figure 34. Global Eosinophilic Granulomatosis Sales Market Share by Application in 2024
Figure 35. Global Eosinophilic Granulomatosis Market Share by Application (2020-2025)
Figure 36. Global Eosinophilic Granulomatosis Market Share by Application in 2024
Figure 37. Global Eosinophilic Granulomatosis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Eosinophilic Granulomatosis Sales Market Share by Region (2020-2025)
Figure 39. Global Eosinophilic Granulomatosis Market Size Market Share by Region (2020-2025)
Figure 40. North America Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Eosinophilic Granulomatosis Sales Market Share by Country in 2024
Figure 43. North America Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Eosinophilic Granulomatosis Market Size Market Share by Country in 2024
Figure 45. U.S. Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Eosinophilic Granulomatosis Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Eosinophilic Granulomatosis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Eosinophilic Granulomatosis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Eosinophilic Granulomatosis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Eosinophilic Granulomatosis Sales Market Share by Country in 2024
Figure 53. Europe Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Eosinophilic Granulomatosis Market Size Market Share by Country in 2024
Figure 55. Germany Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Eosinophilic Granulomatosis Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Eosinophilic Granulomatosis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Eosinophilic Granulomatosis Market Size Market Share by Region in 2024
Figure 68. China Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Eosinophilic Granulomatosis Sales and Growth Rate (K MT)
Figure 79. South America Eosinophilic Granulomatosis Sales Market Share by Country in 2024
Figure 80. South America Eosinophilic Granulomatosis Market Size and Growth Rate (M USD)
Figure 81. South America Eosinophilic Granulomatosis Market Size Market Share by Country in 2024
Figure 82. Brazil Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Eosinophilic Granulomatosis Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Eosinophilic Granulomatosis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Eosinophilic Granulomatosis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Eosinophilic Granulomatosis Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Eosinophilic Granulomatosis Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Eosinophilic Granulomatosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Eosinophilic Granulomatosis Production Market Share by Region (2020-2025)
Figure 103. North America Eosinophilic Granulomatosis Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Eosinophilic Granulomatosis Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Eosinophilic Granulomatosis Production (K MT) Growth Rate (2020-2025)
Figure 106. China Eosinophilic Granulomatosis Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Eosinophilic Granulomatosis Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Eosinophilic Granulomatosis Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Eosinophilic Granulomatosis Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Eosinophilic Granulomatosis Market Share Forecast by Type (2026-2033)
Figure 111. Global Eosinophilic Granulomatosis Sales Forecast by Application (2026-2033)
Figure 112. Global Eosinophilic Granulomatosis Market Share Forecast by Application (2026-2033)